Jonathan Marshall

2.3k total citations
53 papers, 1.6k citations indexed

About

Jonathan Marshall is a scholar working on Pulmonary and Respiratory Medicine, Physiology and General Health Professions. According to data from OpenAlex, Jonathan Marshall has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 7 papers in General Health Professions. Recurrent topics in Jonathan Marshall's work include Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers), Asthma and respiratory diseases (17 papers) and Inhalation and Respiratory Drug Delivery (15 papers). Jonathan Marshall is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers), Asthma and respiratory diseases (17 papers) and Inhalation and Respiratory Drug Delivery (15 papers). Jonathan Marshall collaborates with scholars based in United Kingdom, United States and Canada. Jonathan Marshall's co-authors include R. Garrod, Elizabeth Barley, Peter M. Jones, B. J. Fogg, John Shon, Chris Varma, Omar S. Usmani, Louise Heron, Richard Dekhuijzen and Federico Lavorini and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Thorax.

In The Last Decade

Jonathan Marshall

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Marshall United Kingdom	16	706	395	364	209	174	53	1.6k
David W. Johnson Canada	26	365 0.5×	204 0.5×	311 0.9×	288 1.4×	82 0.5×	95	2.4k
Samantha Adams Netherlands	21	56 0.1×	329 0.8×	429 1.2×	624 3.0×	175 1.0×	64	2.1k
Yi‐Chia Wang Taiwan	20	117 0.2×	327 0.8×	44 0.1×	139 0.7×	113 0.6×	76	1.6k
Uno Fors Sweden	34	36 0.1×	206 0.5×	801 2.2×	334 1.6×	242 1.4×	139	3.2k
James Sebastian United States	22	84 0.1×	109 0.3×	154 0.4×	156 0.7×	69 0.4×	61	2.0k
François Modave United States	22	80 0.1×	104 0.3×	156 0.4×	400 1.9×	62 0.4×	88	1.5k
Jennifer Allen United States	19	59 0.1×	719 1.8×	88 0.2×	230 1.1×	120 0.7×	38	1.3k
Kit Huckvale Australia	20	98 0.1×	348 0.9×	254 0.7×	1.1k 5.4×	66 0.4×	45	2.3k
Silvina Santana Portugal	14	33 0.0×	261 0.7×	492 1.4×	1.0k 5.0×	58 0.3×	40	2.2k
Rachel Kornfield United States	25	28 0.0×	364 0.9×	362 1.0×	270 1.3×	48 0.3×	65	1.9k

Countries citing papers authored by Jonathan Marshall

Since Specialization

Citations

This map shows the geographic impact of Jonathan Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Marshall more than expected).

Fields of papers citing papers by Jonathan Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Marshall. The network helps show where Jonathan Marshall may publish in the future.

Co-authorship network of co-authors of Jonathan Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Marshall. A scholar is included among the top collaborators of Jonathan Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Marshall. Jonathan Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pollack, Michael, et al.. (2025). Prompt Initiation of Budesonide/Glycopyrrolate/Formoterol Fumarate (BGF) After an Exacerbation is Associated With Reduced Exacerbation and Cardiopulmonary Risk in Patients With COPD: The MITOS EROS+CP (US) Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7383–A7383.

Fagerås, Malin, et al.. (2025). Current Smoking and Pharmacological Treatment Responses in Chronic Obstructive Pulmonary Disease: Not Clear-Cut. American Journal of Respiratory and Critical Care Medicine. 211(11). 2223–2224. 1 indexed citations

Pollack, Michael, Joseph Tkacz, Barnabie Agatep, et al.. (2025). Prompt initiation of single-inhaler budesonide/glycopyrrolate/formoterol fumarate (BGF) following a COPD exacerbation reduces exacerbations and cardiopulmonary risk in patients with COPD: insights from the MITOS EROS+CP study in the United States. Current Medical Research and Opinion. 41(7). 1373–1384. 1 indexed citations

Bafadhel, Mona, Jonathan Marshall, Himanshu Parikh, et al.. (2025). Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β2-agonist: post-hoc analyses of KRONOS. Respiratory Research. 26(1). 175–175.

Pollack, Michael, Eleni Rapsomaniki, Antonio Anzueto, et al.. (2024). Reduced Risk of Mortality for COPD Patients Associated with Initiation of Treatment with Single Inhaler Triple Therapy (Budesonide/Glycopyrrolate/Formoterol) Versus Multiple Inhaler Triple Therapy in the United States: The MAZI Study. A3822–A3822. 1 indexed citations

Muro, Shigeo, Tomotaka Kawayama, Hisatoshi Sugiura, et al.. (2024). Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history. Respiratory Research. 25(1). 297–297. 1 indexed citations

Pollack, Michael, Clémentine Nordon, Kirsty Rhodes, et al.. (2024). Association Between Severe Cardiovascular Events and Time Following Exacerbations of COPD: Meta-analyses of EXACOS-CV Observational Studies From 8 Countries. A1865–A1865. 1 indexed citations

Nordon, Clémentine, Kirsty Rhodes, Jennifer K Quint, et al.. (2023). EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies. BMJ Open. 13(4). e070022–e070022. 16 indexed citations

Usmani, Omar S., et al.. (2023). Modeled small airways lung deposition of two fixed-dose triple therapy combinations assessed with in silico functional respiratory imaging. Respiratory Research. 24(1). 226–226. 15 indexed citations

10.

Müllerová, Hana, Jonathan Marshall, Enrico De Nigris, et al.. (2022). Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis. Therapeutic Advances in Respiratory Disease. 16. 2673692975–2673692975. 40 indexed citations

11.

Nigris, Enrico De, Phil McEwan, Jonathan Marshall, Ulf Holmgren, & V. Foos. (2022). POSB65 Economic Burden of COPD in the United Kingdom (2021–2040) Estimated with the COPD Health Outcome Policy and Intervention (CHOPIN) Model. Value in Health. 25(1). S72–S73. 3 indexed citations

12.

Usmani, Omar S., et al.. (2019). An innovative corticosteroid/long-acting β ₂ -agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma. Expert Opinion on Drug Delivery. 16(12). 1367–1380. 5 indexed citations

13.

Terry, Amanda, Moira Stewart, Sonny Cejic, et al.. (2019). A basic model for assessing primary health care electronic medical record data quality. BMC Medical Informatics and Decision Making. 19(1). 30–30. 38 indexed citations

14.

Usmani, Omar S., Federico Lavorini, Jonathan Marshall, et al.. (2018). Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respiratory Research. 19(1). 10–10. 254 indexed citations

15.

Holsbeke, Cedric Van, Jonathan Marshall, Jan De Backer, & Wim Vos. (2014). In vitro lung deposition of fluticasone propionate/formoterol (FP/FORM) pressurized metered dose inhaler (pMDI) with different inhalation profiles. European Respiratory Journal. 44(Suppl 58). P910–P910. 4 indexed citations

16.

Holsbeke, Cedric Van, Jonathan Marshall, Jan De Backer, & Wim Vos. (2014). Median mass aerodynamic diameter (MMAD) and fine particle fraction (FPF): Influence on lung deposition?. European Respiratory Journal. 44(Suppl 58). P912–P912. 10 indexed citations

17.

Jha, Ashok Kumar, Louise Heron, Jonathan Marshall, & W. Dunlop. (2014). Device Handling Errors and the Impact on Quality of Life and Health Care Resource Use in Asthmatic Patients. Value in Health. 17(7). A599–A599. 1 indexed citations

18.

Price, David, et al.. (2012). PRS47 Analysis of New Prescriptions for Long-Acting β2-Agonists in Five European Countries in 2011. Value in Health. 15(7). A568–A568. 1 indexed citations

19.

Maddocks, Heather, Jonathan Marshall, Moira Stewart, et al.. (2010). Quality of congestive heart failure care. Canadian Family Physician. 56(12). 1 indexed citations

20.

Garrod, R., et al.. (2005). Factors associated with success and failure of pulmonary rehabilitation. Thorax. 60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact